Cargando…
Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris
Autores principales: | Moore, Angela Y., Hurley, Kara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720249/ https://www.ncbi.nlm.nih.gov/pubmed/36478983 http://dx.doi.org/10.1016/j.jdcr.2022.10.035 |
Ejemplares similares
-
Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
por: Jiang, Christina, et al.
Publicado: (2023) -
Successful Management of Severe Recalcitrant Pemphigus Vulgaris with Lenalidomide
por: Jain, Akshay Kumar, et al.
Publicado: (2022) -
Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab
por: Santiago-Vázquez, Marely, et al.
Publicado: (2022) -
Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015) -
Management of recalcitrant oral pemphigus vulgaris with CO(2) laser — Report of two cases
por: Bhardwaj, Ashu, et al.
Publicado: (2010)